Doing more and earning better on each one: volume and per-unit economics improving together, from the company's own acti
The model's full reasoning — Q3 2016 call → NOWe need to determine if management conveys both: (1) rising volume/activity now, and (2) improving per-unit economics due to company's own changes, as a coherent present-tense story. Let's analyze the transcript. The company is Fate Therapeutics, a biotech developing cell therapies. They have clinical trials, product candidates. The "volume" could be clinical trial enrollment, sites, etc. The "per-unit economics" could be trial design improvements, etc. But the question is about business volume and per-unit economics. In a biotech, "volume" might be number of patients, sites, etc. "Per-unit economics" might be cost per patient, or efficiency of manufacturing, etc. Let's read the transcript carefully. Management discusses progress: ProTmune clinical trial, FATE-NK100, ToleraCyte, iPSC platform. They mention "seven U.S. clinical sites are now open for enrollment" - that's activity. They also mention "enrollment is now open under this enhanced protocol" - that's activity. They also mention "we expect to initiate a randomized controlled Phase 2 stage in the first quarter of 2017" - that's future. They also mention "we recently amended our clinical trial protocol to blind both investigators and subjects" - that's a change to improve the study's quality, but is that per-unit economics? It's about trial design, not about business economics. The question is about "volume of business" and "economics or productivity of each unit of that business." In a biotech, the "business" might be the development of products. But the question seems to be about operational improvements like more customers, more orders, etc. Here, the "volume" could be number of clinical sites, number of patients enrolled, etc. The "per-unit economics" could be cost per patient, or efficiency of manufacturing, or something like that. But the transcript does not mention any improvement in per-unit economics. It mentions protocol amendments to improve trial design, but not about cost or profitability. It mentions "we have now initiated clinical translation of our first off-the-shelf product candidate" - that's a milestone, not per-unit economics.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| CRGO | Freightos Limited | Q1 2024 | 2024-05-20 | C+ |
| WRBY | Warby Parker Inc. | Q1 2024 | 2024-05-09 | A |
| AZEK | The AZEK Company Inc. | Q2 2024 | 2024-05-08 | B+ |
| CTRA | Coterra Energy Inc. | Q1 2024 | 2024-05-03 | A |
| MNKD | MannKind Corporation | Q4 2023 | 2024-02-27 | C |
| LILA | Liberty Latin America Ltd. | Q4 2023 | 2024-02-23 | C |
| DASH | DoorDash, Inc. | Q3 2023 | 2023-11-01 | C+ |
| GRBK | Green Brick Partners, Inc. | Q3 2023 | 2023-11-01 | B |
| BZUN | Baozun Inc. | Q2 2023 | 2023-08-28 | D |
| IMAX | IMAX Corporation | Q2 2023 | 2023-07-26 | B+ |
| DAL | Delta Air Lines, Inc. | Q2 2023 | 2023-07-13 | A |
| GVP | GSE Systems, Inc. | Q1 2023 | 2023-05-15 | D |
| TGT | Target Corporation | Q4 2022 | 2023-02-28 | C |
| CNA | CNA Financial Corporation | Q4 2022 | 2023-02-06 | B |
| SYY | Sysco Corporation | Q1 2023 | 2022-11-01 | C+ |
| TMCI | Treace Medical Concepts, Inc. | Q2 2022 | 2022-08-13 | B+ |
| DM | Desktop Metal, Inc. | Q2 2022 | 2022-08-08 | F |
| FLR | Fluor Corporation | Q2 2022 | 2022-08-05 | D |
| SGRY | Surgery Partners, Inc. | Q2 2022 | 2022-08-02 | B+ |
| UPWK | Upwork Inc. | Q2 2022 | 2022-07-27 | C+ |
| SE | Sea Limited | Q1 2022 | 2022-05-17 | F |
| IRTC | iRhythm Technologies, Inc. | Q1 2022 | 2022-05-07 | C+ |
| ZENV | Zenvia Inc. | Q4 2021 | 2022-03-17 | C+ |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| GFS | GLOBALFOUNDRIES Inc. | Q3 2021 | 2021-11-30 | A |
| KTB | Kontoor Brands, Inc. | Q3 2021 | 2021-11-04 | A |
| ADSK | Autodesk, Inc. | Q3 2019 | 2018-11-20 | A |
| PRPO | Precipio, Inc. | Q3 2018 | 2018-11-19 | D |
| UMH | UMH Properties, Inc. | Q3 2018 | 2018-11-02 | C+ |
| LRN | Stride, Inc. | Q1 2019 | 2018-10-23 | B |
| AU | AngloGold Ashanti's | Q2 2018 | 2018-08-20 | B |
| TMHC | Taylor Morrison Home Corporation | Q2 2018 | 2018-08-01 | B |
| ORAN | Orange SA | Q2 2018 | 2018-07-26 | B |
| ROP | Roper Technologies, Inc. | Q2 2018 | 2018-07-26 | A |
| HPE | Hewlett Packard Enterprise Company | Q2 2018 | 2018-05-22 | B+ |
| LAUR | Laureate Education, Inc. | Q1 2018 | 2018-05-13 | B+ |
| NOVT | Novanta Inc. | Q4 2017 | 2018-05-12 | B+ |
| FSS | Federal Signal Corporation | Q1 2018 | 2018-05-12 | A |
| BCOV | Brightcove Inc. | Q1 2018 | 2018-04-26 | B+ |
| ALLY | Ally Financial Inc. | Q1 2018 | 2018-04-26 | B+ |
| HLX | Helix Energy Solutions Group, Inc. | Q1 2018 | 2018-04-24 | B+ |
| TOUR | Tuniu Corporation | Q4 2017 | 2018-03-14 | D |
| UPLD | Upland Software, Inc. | Q4 2017 | 2018-03-08 | C+ |
| INST | Instructure's | Q4 2017 | 2018-02-12 | B+ |
| AVT | Avnet, Inc. | Q2 2018 | 2018-01-25 | B |
| UNH | UnitedHealth Group Incorporated | Q4 2017 | 2018-01-16 | A |
| CPK | Chesapeake Utilities Corporation | Q3 2017 | 2017-11-10 | A |
| HOLX | Hologic, Inc. | Q4 2017 | 2017-11-08 | D |
| RACE | Ferrari N.V. | Q3 2017 | 2017-11-02 | C+ |
| PII | Polaris Inc. | Q3 2017 | 2017-10-24 | C+ |
| IBTX | Independent Bank Group, Inc. | Q3 2017 | 2017-10-24 | A |
| BCE | BCE Inc. | Q2 2017 | 2017-08-05 | B+ |
| CCOI | Cogent Communications Holdings, Inc. | Q2 2017 | 2017-08-03 | B |
| LEA | Lear Corporation | Q2 2017 | 2017-07-26 | B+ |
| ABM | ABM Industries Incorporated | Q2 2017 | 2017-06-08 | B |
| BLKB | Blackbaud, Inc. | Q1 2017 | 2017-05-02 | B+ |
| DAN | Dana Incorporated | Q1 2017 | 2017-05-02 | B |
| SHOO | Steven Madden, Ltd. | Q1 2017 | 2017-04-21 | C |
| GPOR | Gulfport Energy Corporation | Q4 2016 | 2017-02-14 | A |
| BP | BP p.l.c. | Q4 2016 | 2017-02-07 | B+ |
| BDC | Belden Inc. | Q4 2016 | 2017-02-02 | B |
| WYY | WidePoint Corporation | Q3 2016 | 2016-11-09 | D |
| SOHO | Sotherly Hotels Inc. | Q3 2016 | 2016-11-08 | D |
| ULBI | Ultralife Corporation | Q3 2016 | 2016-10-29 | C+ |
| NDSN | Nordson Corporation | Q3 2016 | 2016-08-23 | A |
| VRNS | Varonis Systems, Inc. | Q2 2016 | 2016-08-09 | B+ |
| ESE | ESCO Technologies Inc. | Q2 2016 | 2016-05-03 | A |
| INGR | Ingredion Incorporated | Q1 2016 | 2016-05-01 | B+ |
| RCL | Royal Caribbean Cruises Ltd. | Q1 2016 | 2016-04-29 | C+ |
| CAL | Caleres, Inc. | Q4 2015 | 2016-03-15 | C+ |
| HD | The Home Depot, Inc. | Q4 2015 | 2016-02-23 | A |
| JHX | James Hardie Industries plc | Q3 2016 | 2016-02-19 | B+ |
| HXL | Hexcel Corporation | Q4 2015 | 2016-01-22 | B+ |
SYY · Q1 2023 → YESThe question is whether management conveys TWO improvements happening AT THE SAME TIME: (1) volume of business RISING NOW, and (2) economics or productivity OF EACH UNIT getting BETTER due to company'...YES The transcript shows management describing both rising volume (sales +16.2%, U.S. Foodservice volume +7.3%, local case volume +5.4%, more than 1.4× market growth, net new customer wins) and improving per-unit economics (GP per case grew in all four 5th consecutive quarter; gross profit dollars per case increasing) as already occurring in the current quarter. They attribute the per-unit gains to company actions—strategic sourcing, team-based selling, Sysco Your Way service model, pricing tools, and supply-chain productivity improvements—while also noting inflation pass-through. Management presents these 2 improvements together as the present state of the business (not merely a target), even though OpEx productivity is still below historical levels and expected to improve later in the year. The answer is therefore YES. No other transcript section contradicts the dual improvement being conveyed as current. The question is answered YES.
IMAX · Q2 2023 → YESThe question is whether management conveys TWO improvements happening AT THE SAME TIME: (1) volume of business RISING NOW, and (2) economics or productivity OF EACH UNIT getting BETTER due to company ...YES The transcript shows both volume rising (signings up to 84 YTD vs 47 last year, installations doubled in Q2, box office +8% to $268M, revenue +32%) and per-unit economics improving (gross margins 59%, gross profit +31% with 15% growth 64% margin segment and 42% growth 36% margin segment, SG&A % of revenue down 700 bps to 33%, EBITDA margin 35.4%, driven by mix, profit flow-through, sales/hybrid arrangements, cost discipline, and operating leverage from company actions like programming and system mix). Management presents these as current state, not targets. So the answer is YES. The two improvements are happening simultaneously as described.
NDSN · Q3 2016 → YESThe question is: Does management convey that TWO improvements are happening at the same time: (1) volume of business is RISING NOW, and (2) the economics or productivity OF EACH UNIT are simultaneousl...YES Management describes both rising volume (6% sales growth, 4% organic, strong order rates, 22% backlog increase) and improving per-unit economics (operating margin up 3 points, gross margin up 2 points, incremental margin 77%, driven by volume leverage plus continuous improvement initiatives and the Nord business system) as already occurring in the current quarter. They attribute the per-unit gains mainly to company actions (new products, tiering, Nordson business system, restructuring-enabled improvements) rather than external prices or market conditions. The two improvements are presented together as the present state of the business.